2. Variations to the terms of marketing authorisations for medicinal
products ***I - Counterfeiting of medicinal products (debate)

Report: on the proposal for a directive of the European Parliament and of
the Council amending Directive 2001/82/EC and Directive 2001/83/EC as
regards variations to the terms of marketing authorisations for medicinal
products [COM(2008)0123 - C6-0137/2008 - 2008/0045(COD)] - Committee on the
Environment, Public Health and Food Safety. Rapporteur: Franoise
Grossette (A6-0346/2008)

Commission statement: Counterfeiting of medicinal products

Franoise Grossette introduced the report.

Gnter Verheugen (Vice-President of the Commission) made the statement.

The following spoke: Petya Stavreva (draftsman of the opinion of the AGRI
Committee), Cristina Gutirrez-Cortines, on behalf of the PPE-DE Group,
Dagmar Roth-Behrendt, on behalf of the PSE Group, Alessandro Foglietta, on
behalf of the UEN Group, Ji? Ma?tlka, on behalf of the GUE/NGL Group,
Kathy Sinnott, on behalf of the IND/DEM Group, Irena Belohorsk, Non-
attached Member, Eija-Riitta Korhola, Daciana Octavia Srbu, Marios
Matsakis, Hanne Dahl, Zuzana Roithov, Giovanna Corda, Thomas Ulmer,
Genowefa Grabowska, Cristian Silviu Bu?oi and Amalia Sartori.

The following spoke under the 'catch-the-eye' procedure: Miroslav
Mikol?ik, Dagmar Roth-Behrendt, Jorgo Chatzimarkakis, Dumitru Oprea,
Donato Tommaso Veraldi and Emmanouil Angelakas.

The following spoke: Gnter Verheugen and Franoise Grossette.

The debate closed.

Vote: minutes of 22.10.2008, item 4.6.

